GlassScriptPhysician profile
Mary C Sutton
NPI 1194319004
$1,204.04
in general payments reported to CMS, 2019-2025
10 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $736 · 2024: $276 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $392.21 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $163.10 | 2022 | |
| Amgen INC. | $160.64 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $154.33 | 2022 | |
| Novartis Pharmaceuticals Corporation | $143.17 | 2024-2025 | |
| Beigene USA, INC. | $118.39 | 2022 | |
| Novo Nordisk INC | $31.56 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.57 | 2024 | Tagrisso |
| Grt US Holding, INC. | $13.65 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.